This page is being reviewed

We’re double-checking this content before publishing it — it’ll be available here shortly.

In the meantime, browse the published guides or contact the rooms.

Take-home

A single intramuscular injection of vitamin K at birth prevents vitamin K deficiency bleeding (VKDB): a rare but potentially fatal condition. Without prophylaxis, late VKDB affects around 8.8 per 100,000 babies in high-income countries (roughly 1 in 11,000), almost all of them breastfed. (That isn’t a reason to avoid breastfeeding: breast milk is simply naturally low in vitamin K, which the injection tops up.) With routine intramuscular prophylaxis, the Australian late-VKDB rate is around 0.6 per 100,000 (Zurynski et al., APSU 1993–2017), roughly 1 in 165,000. The injection is recommended by the NHMRC, RANZCOG and the RACP and has been standard in maternity care for decades.

What is vitamin K?

Vitamin K is essential for blood clotting. Without enough vitamin K, babies can develop serious bleeding problems because their blood cannot clot properly.

Why don't babies have enough vitamin K?

Very little vitamin K crosses the placenta from mother to baby during pregnancy
Breast milk contains only small amounts of vitamin K, average around 1 µg/L at baseline, compared with about 55 µg/L in infant formula
A baby’s gut bacteria, which make vitamin K later in life, aren’t established until several weeks after birth
A baby’s liver is immature and does not store vitamin K well

Vitamin K deficiency bleeding (VKDB)

Without vitamin K, babies can bleed into any part of the body. VKDB is rare, but serious when it happens.

Types of VKDB

Green — usually fine

Early VKDB (first 24 hours)

Severe bleeding, often internal
Rare — almost always linked to maternal medication (anti-seizure drugs such as phenytoin or carbamazepine, some tuberculosis drugs, or warfarin)

Amber — be alert

Classic VKDB (days 2–7)

Bleeding from the umbilicus, gastrointestinal bleeding, or bruising
Affects 0.25–1.7% of newborns who do not receive vitamin K (roughly 1 in 60 to 1 in 400)
Usually detected early, less often catastrophic than late VKDB

Red — act now

Late VKDB (2 weeks to 6 months)

Often brain haemorrhage
Affects about 8.8 per 100,000 (≈ 1 in 11,000) in high-income countries, almost exclusively in babies who are exclusively breastfed
Internationally, a substantial share of late VKDB involves bleeding into the brain; in the APSU surveillance (58 cases over 1993–2017), all six deaths were caused by intracranial haemorrhage
This is the type the injection is most important for preventing

Why late VKDB is the most feared type

Late VKDB can occur suddenly in a previously healthy, thriving, breastfed baby. Around a third to a half of affected babies have bleeding into the brain, often before any bruising or bleeding is visible externally. The injection at birth protects for the full 6-month window.

Vitamin K administration

Injection (recommended)

Intramuscular injection, single dose at birth

Single dose of 1 mg into the thigh muscle soon after birth (NHMRC; babies under 1.5 kg receive 0.5 mg)
Most effective method: protects for months
Takes seconds to give; most babies settle with a feed or cuddle straight after
Routinely offered at every maternity hospital

Oral (alternative, on request)

Oral, requires three doses

3 doses required: at birth, at 3–5 days, and at 4 weeks of age (NHMRC dose schedule): your midwife or paediatrician gives the exact dose; this is not a pharmacy purchase
Less reliable absorption, especially in unwell, vomiting, or liver-affected babies
The 4-week dose is the one most often missed, and a missed dose reopens the window for late VKDB. In the APSU surveillance, of the few VKDB babies who had received oral vitamin K, 86% had not completed all three doses
Even when all three doses are given, oral prophylaxis is less protective against late VKDB than a single injection

The recommendation

The injection is recommended by the NHMRC, RANZCOG, and the Royal Australasian College of Physicians, and is the position of every Australian maternity hospital. If you prefer oral, we will honour that, with clear written instructions to make sure all three doses are given on schedule.

Common concerns

Is the injection painful?

The injection is quick. Most babies cry more at being held still than at the needle itself. A feed or skin-to-skin immediately afterwards settles them within a minute or two.

Are there any side effects?

Vitamin K injection has a strong safety record over more than 20 years (Better Health Channel). The only common side effect is mild soreness at the injection site, which settles in a day. Serious allergic reactions are extraordinarily rare.

Is there a link to childhood cancer?

No. A single small UK study in the early 1990s suggested a possible association with leukaemia. Many large follow-up studies since, involving several million children across Europe, North America and Australia, have found no link between vitamin K injection and any cancer. The original concern has been definitively laid to rest.

What if I decline vitamin K?

We will discuss this with you in detail and respect your choice, but we will also make sure you understand the risks. The surveillance data are sobering: in the 25-year APSU series, vitamin K had not been given in 57% of VKDB cases — most often because it was declined — and every one of the six deaths was caused by bleeding into the brain. Half of those deaths were in babies born at home whose parents had declined vitamin K.

If you are still weighing it up:

Oral is a reasonable middle path if the injection is your concern, it is far better than nothing, provided all three doses are completed (the 4-week dose included)
If you decline entirely, your baby must be watched closely for any unexplained bruising or bleeding across the whole first 6 months, and late VKDB often strikes a well, thriving baby with no warning
Any elective procedure (for example, circumcision or frenotomy) carries substantially more bleeding risk without prophylaxis
We will usually ask you to sign an informed-refusal form

Warning signs of VKDB

Seek same-day review / call 000 if your baby shows:

Physical signs

Unexplained bruising or bleeding, anywhere
Blood in the stool or urine
Bleeding from the umbilical cord stump or injection site
Nosebleeds or bleeding gums
Unusual pallor (pale skin): a sign of blood loss
Prolonged jaundice lasting beyond 2 weeks (term) or 3 weeks (preterm): this can indicate liver or biliary disease, which impairs vitamin K absorption, and also needs urgent review on its own merits (see Neonatal jaundice)

Behavioural signs of bleeding in the brain

Unusual drowsiness, difficulty waking, or floppiness
Persistent vomiting
Seizures or unusual jerking movements
High-pitched cry, bulging fontanelle, or rapid head growth

The short version

Key takeaways

A single vitamin K injection at birth prevents a rare but serious bleeding condition
Without vitamin K, late VKDB affects about 8.8 per 100,000 babies (≈ 1 in 11,000) in high-income countries, and a substantial fraction have brain bleeding
Injection (a single dose) is more reliable than oral (three doses)
Long-standing recommendation, supported by NHMRC, RACP, and RANZCOG
Please talk to your midwife or paediatrician early if you have questions